# Facible BioDiagnostics, Inc. — Regulation A 1-A POS

Facible BioDiagnostics, Inc. of MERIDIAN, ID filed a Regulation A 1-A POS with the SEC on 2022-08-09. Aggregate offering: $40.0M (Tier 2). Industry: Other.

## Offering

- Filed: 2022-08-09
- Form: 1-A POS
- Accession: 0001910594-22-000012
- Tier: Tier 2
- Total aggregate offering: $40.0M
- Issuer portion: $36.7M
- Selling securityholders: $3.3M
- Price per security: $5.8000
- Securities offered: Equity (common or preferred stock)
- Audit status: Audited
- Auditor: Assurance Dimensions
- Jurisdictions: 128 states/territories

## Issuer

- CIK: 0001910594
- Organized in: DE
- Incorporated: 2022
- Address: 366 SW 5TH AVE, STE. 104, MERIDIAN, ID, 83642
- Phone: 2087576996
- Employees: 8 full-time, 2 part-time

## Financial snapshot (as filed)

- Total assets: $1.4M
- Cash & equivalents: $449K
- Total liabilities: $9.1M
- Stockholder equity: $-7.6M
- Net income: $-6.4M

## People (1)

| Name | Role | Location |
| --- | --- | --- |
| Nicholas Antaki | Signer | SCOTTSDALE, AZ |

## Other Reg A filings by this issuer (4)

| Filed | Form |
| --- | --- |
| [2022-10-07](https://search.stillhousedata.com/rega/0001910594-22-000019) | 1-A POS |
| [2022-09-20](https://search.stillhousedata.com/rega/0001910594-22-000015) | 1-A POS |
| [2022-07-21](https://search.stillhousedata.com/rega/0001910594-22-000009) | 1-A/A |
| [2022-05-09](https://search.stillhousedata.com/rega/0001910594-22-000005) | 1-A |

## More

- [CIK 1910594 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1910594&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/rega/0001910594-22-000012.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.